Artivion (AORT) Tops Q4 EPS by 20c ; Offers Guidance

Artivion (NYSE: AORT) reported Q4 EPS of $0.11, $0.20 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $93.7 million versus the consensus estimate of $89.27 million.

GUIDANCE:

Artivion sees FY2024 revenue of $382-396 million, versus the consensus of $384.3 million.

For earnings history and earnings-related data on Artivion (AORT) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c